Evidence map›Paper›PMID 28614711›Full record

ArticleCell reports2017

DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific.

Dayton J Goodell, Vincent Zaegel, Steven J Coultrap, Johannes W Hell, K Ulrich Bayer

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Synaptic Plasticity as a Function of the Temporal Derivative.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Molecular Physiology of the Neuronal Synapse.Current issues in molecular biology · 2026
    Review
  5. Review
  6. The Ubiquitin-Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Synaptic memory and CaMKII.Physiological reviews · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dayton J GoodellDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Program in Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Vincent ZaegelDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Steven J CoultrapDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Johannes W HellDepartment of Pharmacology, School of Medicine, University of California, Davis, Davis, CA 95616, USA.
K Ulrich BayerDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Program in Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: ulli.bayer@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of California, Davis · US

Funding

ZEBRAFISH TRANSGENIC CORE - ROCKY MOUNTAIN NEUROLOGICAL DISORDERS CORE CENTERP30NS048154 · NINDS · UNIVERSITY OF COLORADO DENVER · PI RIBERA, ANGELES BADELL · 2004 to 2020
$10.1M
CaMKII substrate-selection in opposing forms of synaptic plasticityR01NS081248 · NINDS · UNIVERSITY OF COLORADO DENVER · PI K. Ulrich Bayer · 2013 to 2026
$4.9M
Role of a-actinin in Cav1.2 FunctionR01AG055357 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2016 to 2026
$4.0M
Molecular Mechanisms of Postsynaptic AMPA Receptor LocalizationR01MH097887 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2014 to 2018
$2.5M
CaMKII in global cerebral ischemiaR01NS080851 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BAYER, K. ULRICH, HERSON, PACO S · 2013 to 2017
$2.1M
Neuroscience Training GrantT32NS099042 · NINDS · UNIVERSITY OF COLORADO DENVER · PI Nidia Calero, GIDON S FELSEN · 2016 to 2026
$2.1M
DAPK1 regulation and involvement in LTDF31NS092265 · NINDS · UNIVERSITY OF COLORADO DENVER · PI GOODELL, DAYTON JOSHUA · 2015 to 2017
$86k
NIA NIH HHS R01 AG055357NIMH NIH HHS R01 MH097887NINDS NIH HHS F31 NS092265NINDS NIH HHS P30 NS048154NINDS NIH HHS R01 NS080851NINDS NIH HHS R01 NS081248NINDS NIH HHS T32 NS099042
6 · The paper itself

Abstract

The death-associated protein kinase 1 (DAPK1) is a potent mediator of neuronal cell death. Here, we find that DAPK1 also functions in synaptic plasticity by regulating the Ca

Indexed as

Amino Acid SequenceAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Death-Associated Protein KinasesHEK293 CellsHumansLong-Term PotentiationLong-Term Synaptic DepressionMemoryMiceNeuronal PlasticityPhosphorylationReceptors, N-Methyl-D-AspartateTransfectionCalcium-Calmodulin-Dependent Protein Kinase Type 2DAPK1 protein, humanDapk1 protein, mouseDeath-Associated Protein KinasesNR2B NMDA receptorReceptors, N-Methyl-D-AspartatecalcineurinCaMKIIDAPK1death-associated protein kinasedendritic spineGluN2BhippocampusLTDLTPsynapse

Identifiers

PMID28614711
PMCPMC5549467
OpenAlexW2625709293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.